• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A study on early hearing impairment with essential hypertension].

作者信息

Zhang Jing, Zhou Huifang, Zhang Geng, Xu Yi

机构信息

Department of Otorhinolaryngology, the General Hospital of Tianjin Medical University, Tianjin, 300052, China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Aug;23(16):731-3.

PMID:20041605
Abstract

OBJECTIVE

To study the characteristic of hearing loss in essential hypertension.

METHOD

Sixty-eight cases (136 ears) of patients with essential hypertension were divided into two groups, i.e. group A, patients without retinal arteriosclerosis (35 cases, 70 ears ) and group B, patients with retinal arteriosclerosis (33 cases, 66 ears ). The control group consisted of 30 cases (60 ears) of the same sex and same age. All people were measured by pure tone audiometry and distortion product otoacoustic emissions.

RESULT

The pure tone thresholds measured in group B hypertensive patients were significantly higher than in the normal controls (P<0.05), whereas pure tone thresholds in group A were not different from those in the control group (P>0.05). From 1000 to 8000 Hz, DPOAE amplitudes of hypertensive group A and group B were lower than that in control group (P<0.01). Only on the frequency points of 4000 Hz, the detection rate of DPOAE in group B was lower than that in control group (P<0.05).

CONCLUSION

Hypertension is a risk factor of degeneration of the hearing apparatus. The hearing function of hypertensive patients has probability to be impaired, although they do not feel hearing loss.

摘要

相似文献

1
[A study on early hearing impairment with essential hypertension].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Aug;23(16):731-3.
2
[Analysis of evoked otoacoustic emission in normal pure tone hearing thresholds patients with aural fullness].正常纯音听力阈值伴耳闷患者的诱发耳声发射分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Nov;23(22):1023-6.
3
[Correlation between auditory threshold and transitory evoked otoacoustic emissions].[听阈与瞬态诱发耳声发射之间的相关性]
Srp Arh Celok Lek. 2002 May-Jun;130 Suppl 1:8-11.
4
Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.白塞病患者的听力损失:一项听力学及瞬态诱发耳声发射研究
J Laryngol Otol. 2010 Jan;124(1):10-5. doi: 10.1017/S0022215109991083. Epub 2009 Sep 29.
5
[Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].[内耳听力损失对瞬态耳声发射(TEOAE)和畸变产物耳声发射(DPOAE)的影响]
Laryngorhinootologie. 1996 Dec;75(12):709-18. doi: 10.1055/s-2007-997664.
6
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.影响畸变产物耳声发射对耳毒性听力损失敏感性的因素。
Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99.
7
Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.使用畸变产物耳声发射和听觉稳态响应的同时测量来估计听阈。
J Acoust Soc Am. 2011 Feb;129(2):840-51. doi: 10.1121/1.3531934.
8
Detection of pseudohypacusis: a prospective, randomized study of the use of otoacoustic emissions.伪聋的检测:一项关于耳声发射应用的前瞻性随机研究。
Ear Hear. 2003 Dec;24(6):518-827. doi: 10.1097/01.AUD.0000100206.96363.05.
9
[Evoked otoacoustic emission behavior in clinical sensorineural hearing loss].
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1993;28(1):22-5, 59.
10
Results for audiology and distortion product and transient evoked otoacoustic emissions in patients with systemic lupus erythematosus.系统性红斑狼疮患者的听力学、畸变产物耳声发射和瞬态诱发耳声发射结果。
J Laryngol Otol. 2010 Feb;124(2):137-40. doi: 10.1017/S0022215109991332. Epub 2009 Oct 26.

引用本文的文献

1
Clinical manifestations of aural fullness.耳闷的临床表现。
Yonsei Med J. 2012 Sep;53(5):985-91. doi: 10.3349/ymj.2012.53.5.985.